Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratorio de Genetica e Diagnostico Molecular, |
RCV003130940 | SCV003808083 | uncertain significance | Rothmund-Thomson syndrome type 2 | 2022-08-13 | criteria provided, single submitter | clinical testing | ACMG classification criteria: PM2 moderated |
Gene |
RCV004775348 | SCV005383380 | uncertain significance | not provided | 2024-02-12 | criteria provided, single submitter | clinical testing | Identified with a second variant (phase unknown) in a patient with Rothmund-Thomson syndrome in published literature (PMID: 28486640); In silico analysis supports that this variant does not alter splicing; This variant is associated with the following publications: (PMID: 28486640) |
Mendelics | RCV003130940 | SCV005419061 | likely pathogenic | Rothmund-Thomson syndrome type 2 | 2024-12-02 | criteria provided, single submitter | clinical testing | The NM_004260.4(RECQL4):c.1483+27_1483+37del variant has a GnomAD 4.1.0 frequency of 0.000003161 (5 heterozygotes) with no homozygotes. This variant occurs close to the messenger RNA processing site (splicing donor site). It has been previously described on multiple occasions in the medical literature associated with the syndrome Rothmund-Thompson (https://pubmed.ncbi.nlm.nih.gov/34341987/). The combination of the molecular mechanism (which is possibly related to changes in mRNA processing), the characteristics of the region where it is found and the correlation of this gene with clinical symptoms indicate that this variant is likely pathogenic. It was found in homozygous state. |